FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

3,819 letters. Newest first.

  1. Fresenius Kabi USA LLC

    FDA warns Fresenius Kabi USA over manufacturing failures for sterile injectables at Melrose Park, including endotoxin contamination and media fill failures.

    High risk
  2. Babikian Healthcare Products CJSC

    FDA warns Babikian Healthcare Products over manufacturing quality failures for over-the-counter drugs, including missing identity and finished-product testing.

    High risk
  3. Curia New York, Inc.

    FDA warned Curia New York's Rensselaer, New York API plant that undocumented lab injections, shredded records and shared passwords violate CGMP.

    High risk
  4. Bentley Laboratories LLC

    Bentley Laboratories LLC was cited for CGMP violations and for marketing unapproved acne drugs.

    High risk
  5. Celmade

    FDA warned Celmade over websites selling unapproved, misbranded injectable botulinum toxin products to U.S. consumers.

    High risk
  6. Andrighetto Produce Inc dba Shasta Produce Inc

    FDA found Andrighetto Produce lacked a Foreign Supplier Verification Program for most imported fresh produce and hazard-analysis review.

    High risk
  7. South Asian Food Inc.

    South Asian Food Inc. lacked seafood HACCP import verification and pest controls for imported dried seafood.

    High risk
  8. Bo Wah Enterprises Inc

    Bo Wah Enterprises lacked required supplier checks for imported yam, mushroom, and sesame paste.

    Medium
  9. Stokes Healthcare Inc. dba Epicur Pharma

    FDA warned Epicur Pharma over website claims for compounded omeprazole and buprenorphine animal drugs that are false or misleading.

    High risk
  10. American Pharma Mfg. Inc.

    FDA warns American Pharma Mfg. of serious dietary supplement manufacturing violations at its Ontario, CA facility.

    High risk
  11. Wilson Livestock

    Wilson Livestock sold a heifer with excess desfuroylceftiofur residue and used a cephalosporin drug outside approved labeling for disease prevention.

    High risk
  12. Fil-Bay Import, Inc.

    Fil-Bay Import lacked required foreign supplier safety plans for many imported foods and canned-food processing checks.

    High risk
  13. Good Stuff Cacao

    FDA warns Good Stuff Cacao that disease claims make its cacao, tea, honey, goji unapproved new drugs.

    Low
  14. Wellmill, LLC dba Vitamix Laboratories

    FDA warned Vitamix Laboratories that its juice-with-probiotics products were adulterated because it lacked required hazard controls and a 5-log pathogen reduction.

    High risk
  15. Middlefield Original Cheese Cooperative

    FDA warns Middlefield Original Cheese Cooperative about Listeria and insanitary conditions in its ready-to-eat cheese.

    High risk
  16. VeganicSKN Limited

    FDA warns VeganicSKN over manufacturing rule failures; drug shipped after failing test and high-risk ingredient not identity-tested.

    High risk
  17. Stream2Sea, LLC

    FDA found Stream2Sea, an OTC drug maker in Bowling Green, Florida, released drug batches without finished-product testing, raw material identity testing, or validated cleaning.

    Medium
  18. Kellin Chemicals Co., Ltd. - Zhangjiagang

    Kellin Chemicals' API site refused FDA inspection, so FDA calls its drugs adulterated.

    High risk
  19. Empower Clinic Services, LLC dba Empower Pharmacy

    FDA warned Empower Pharmacy over unapproved compounded semaglutide/tirzepatide copies and sterile manufacturing deficiencies that put patients at risk.

    High risk
  20. NexCell Scientific Inc

    NexCell Scientific markets an unapproved, unlicensed umbilical cord blood cell product with serious manufacturing violations.

    High risk
  21. kdc/one Chatsworth, Inc.

    FDA warned kdc/one Chatsworth of CGMP violations in OTC drugs, including missing carcinogen testing and storage temperature failures.

    High risk
  22. Union Trade Inc.

    FDA warns Union Trade Inc. that it lacked required foreign supplier verification for imported radish, peanuts, mushrooms, and fruit.

    High risk
  23. Advance-Esthetic LLC

    FDA says Advance-Esthetic markets three Zemits body-contouring devices without the required FDA clearance or approval.

    Medium
  24. BioDrive, Inc.

    FDA warned BioDrive that its Evolv GLP-1 Biomimetic dietary supplement is adulterated over the new dietary ingredient EV1-Peptide and safety concerns.

    High risk
  25. Raaw Energy LLC

    FDA: Raaw Energy's frozen raw dog food contained Salmonella, Listeria and Campylobacter and was made under insanitary conditions.

    High risk
  26. Lion Street Medical, d/b/a Pensar Medical LLC

    FDA warns Pensar Medical over unreported wound-therapy injuries and missing device reporting procedures.

    High risk
  27. Binh Minh Tofu

    FDA warned Binh Minh Tofu that its ready-to-eat tofu was adulterated after a March 2026 inspection found unsafe cooling, sanitation and hygiene failures.

    High risk
  28. Quantum Star LLC

    FDA found Quantum Star LLC imported pig ears contaminated with Salmonella without an FSVP for its animal foods.

    High risk
  29. Viva Raw LLC

    Viva Raw LLC's raw pet foods were found contaminated with Salmonella and Listeria, leading to a Class I recall.

    High risk
  30. Ohom Padmaavathii, LLC

    Ohom Padmaavathii lacked an FSVP for imported flour, FDA says after inspection.

    Medium
  31. LDNN Produce Inc.

    LDNN Produce Inc. lacked an FSVP for imported mushrooms and fresh yams, FDA says.

    Medium
  32. Specialty Health Products CO, LLC

    Specialty Health Products was cited for quality-system, unapproved marketing, and listing violations for its Hydro-San and Aqua Cleanse colonic irrigation devices.

    High risk
  33. Shouly Import Corp.

    Shouly Import Corp. lacked FSVP records for imported roasted white sesame, feta, and baklava, FDA found.

    Medium
  34. Yam Man Foods LLC

    FDA warns Yam Man Foods it lacked an FSVP for imported Bammies, peppers, and breadfruit.

    Medium
  35. Accra Supermarket

    FDA warns Accra Supermarket it lacked required foreign supplier safety records for imported yams, ice cream, and peanuts.

    Medium
  36. Bausch & Lomb Inc.

    FDA warns Bausch & Lomb of persistent microbial contamination and poor aseptic controls at its Tampa sterile drug plant.

    High risk
  37. H2 BEV, LLC and H2 RENU, INC

    FDA warns H2 BEV and H2 RENU over unregistered acidified hydrogen beverages with unmonitored pasteurization and drug claims.

    High risk
  38. Happy Farm Botanicals, Inc.

    Happy Farm Botanicals, an OTC drug maker in Hyattsville, MD, cited for skipping ingredient identity tests and stability testing, repeat violations.

    High risk
  39. Stephen J. Fallon, Ph.D.

    FDA warns clinical investigator Stephen J. Fallon, Ph.D. over consent and record failures in an HIV self-test study.

    High risk
  40. Jabil Inc.

    FDA warned Jabil Inc. after an inspection found inadequate investigations of mold and sterility failures at its sterile injectable contract manufacturer.

    High risk
  41. Fresenius Medical Care AG & Co. KGaA

    Fresenius Medical Care's Ogden, Utah plant failed to investigate leaking peritoneal dialysis bags, leading to a 2026 recall.

    High risk
  42. Peak Performance Peptides

    Peak Performance Peptides sold unapproved injectable peptide drugs, including semaglutide and retatrutide, without FDA approval.

    High risk
  43. Royal Peptides LLC

    FDA warned Royal Peptides LLC that seven peptide products sold on its website are unapproved new drugs.

    High risk
  44. NuScience Peptides LLC

    FDA warned NuScience Peptides that it sells unapproved injectable peptide drugs, including GLP-1 and tesamorelin products, on its website.

    High risk
  45. Peptide Partners LLC

    Peptide Partners LLC sold seven unapproved injectable peptide drugs online with disease-treatment claims, FDA says.

    High risk
  46. TXP Innovations LLC dba Tex Peptides

    FDA warned Dallas peptide seller TXP Innovations (Tex Peptides) that its website sells unapproved injectable drugs, including semaglutide and tirzepatide.

    High risk
  47. Reliance Life Sciences Private Limited

    FDA warned India's Reliance Life Sciences over falsified microbiology records and aseptic failures in sterile drug production, prompting a recall.

    High risk
  48. Shoolin Pharma Chem LLP

    Shoolin Pharma Chem, an Indian API maker, warned over filthy conditions, missing test data, and cleaning failures; all U.S. APIs recalled.

    High risk
  49. B&P Mutual Corp

    B&P Mutual Corp lacked required FSVP records for imported syrup, molasses, and chocolate-free candy, FDA says.

    Medium
  50. PReye, LLC

    FDA warned PReye, LLC that its unapproved eye drop PReye Vitamin SEE was made without sterile controls in an unclassified office.

    High risk